A Phase I/II/Pharmacodynamic Study of Hydroxychloroquine in Combination With Gemcitabine/Abraxane to Inhibit Autophagy in Pancreatic Cancer.
Phase of Trial: Phase I/II
Latest Information Update: 07 Feb 2018
At a glance
- Drugs Gemcitabine (Primary) ; Paclitaxel (Primary) ; Hydroxychloroquine
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 01 Feb 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.
- 10 Jun 2017 Biomarkers information updated
- 24 Jan 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.